These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10765052)

  • 21. Facial synkinesis as a first symptom of multiple sclerosis.
    Tacconi P; Peltz MT; Lorefice L; Marrosu MG; Marrosu F
    Mult Scler; 2016 Oct; 22(11):1499-1501. PubMed ID: 26245215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Botulinum toxin therapy in hemifacial spasm: clinical and electrophysiologic studies.
    Geller BD; Hallett M; Ravits J
    Muscle Nerve; 1989 Sep; 12(9):716-22. PubMed ID: 2630907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation of botulinum toxin dose with neurophysiological parameters of efficacy and safety in the glabellar muscles: a double-blind, placebo-controlled, randomized study.
    Alimohammadi M; Andersson M; Punga AR
    Acta Derm Venereol; 2014 Jan; 94(1):32-7. PubMed ID: 23975053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Botulinum toxin type A reconstituted in lidocaine with epinephrine for facial rejuvenation: results of a participant satisfaction survey.
    Kim A; Jung J; Pak A
    Cutis; 2013 Jul; Suppl():13-8. PubMed ID: 24308152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J; Entner T
    Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Experience with botulinum toxin treatment of facial-cervical dystonias and hemifacial spasm].
    Erbguth F; Claus D; Neundörfer B
    Nervenarzt; 1990 Oct; 61(10):611-4. PubMed ID: 2274093
    [No Abstract]   [Full Text] [Related]  

  • 27. [Simultaneous injection of lidocaine improves predictability of effect of botulinum toxin].
    Haubner F
    Laryngorhinootologie; 2009 Dec; 88(12):764. PubMed ID: 20050293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Facial myokymia caused by pontine lesions and central fever in multiple sclerosis--case report].
    Gold R; Kappos L
    Schweiz Rundsch Med Prax; 1991 Nov; 80(47):1327-9. PubMed ID: 1957099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of two different formulations of botulinum toxin A for the treatment of blepharospasm and hemifacial spasm.
    Wu CJ; Shen JH; Chen Y; Lian YJ
    Turk Neurosurg; 2011; 21(4):625-9. PubMed ID: 22194126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Focal dystonias and facial hemispasm: treatment with botulinum A toxin].
    Astarloa R; Morales B; Sánchez V; Peñafiel N; Rábano J; Oliván J; García de Yébenes J
    Arch Neurobiol (Madr); 1991; 54 Suppl 3():44-51. PubMed ID: 1810208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Focal dystonias and facial hemispasm: treatment with botulinum A toxin].
    Astarloa R; Morales B; Sánchez V; Peñafiel N; Rábano J; Oliván J; García de Yébenes J
    Arch Neurobiol (Madr); 1991; 54(5):210-7. PubMed ID: 1804035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Uncommon foreign body reaction caused by botulinum toxin.
    Pontes HA; Pontes FS; de Oliveira GF; de Almeida HA; Guimarães DM; Cavallero FC
    J Craniofac Surg; 2012 Jul; 23(4):e303-5. PubMed ID: 22801160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation and selecting indications for the treatment of improving facial morphology by masseteric injection of botulinum toxin type A.
    Gaofeng L; Jun T; Bo P; Bosheng Z; Qian Z; Dongping L
    J Plast Reconstr Aesthet Surg; 2010 Dec; 63(12):2026-31. PubMed ID: 20116356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Botulinum toxin for the treatment of oro-facial-lingual-masticatory tardive dyskinesia.
    Rapaport A; Sadeh M; Stein D; Levine J; Sirota P; Mosheva T; Stir S; Elitzur A; Reznik I; Geva D; Rabey JM
    Mov Disord; 2000 Mar; 15(2):352-5. PubMed ID: 10752596
    [No Abstract]   [Full Text] [Related]  

  • 35. Gummy smile and botulinum toxin: a new approach based on the gingival exposure area.
    Mazzuco R; Hexsel D
    J Am Acad Dermatol; 2010 Dec; 63(6):1042-51. PubMed ID: 21093661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spastic paretic hemifacial contracture as a presenting feature of multiple sclerosis.
    Koutsis G; Breza M; Evangelopoulos ME; Anagnostouli M; Andreadou E; Karagiorgis G; Kokotis P; Kilidireas C; Karandreas N
    Mult Scler Relat Disord; 2017 Apr; 13():112-115. PubMed ID: 28427691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The place of the botulinum toxin in the management of multiple sclerosis.
    Habek M; Karni A; Balash Y; Gurevich T
    Clin Neurol Neurosurg; 2010 Sep; 112(7):592-6. PubMed ID: 20615606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Botulinum toxin injections under electromyographic guidance].
    Bogucki A
    Neurol Neurochir Pol; 1998; 32 Suppl 1():85-93. PubMed ID: 9608557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inspiratory stridor secondary to palatolingual myokymia in a Maltese dog.
    Vanhaesebrouck AE; Bhatti SF; Bavegems V; Gielen IM; Van Soens I; Vercauteren G; Polis I; Van Ham LM
    J Small Anim Pract; 2010 Mar; 51(3):173-5. PubMed ID: 20070491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Facial myokymia in multiple system atrophy.
    Blunt SB; Khalil NM; Perkin GD
    Mov Disord; 1997 Mar; 12(2):235-8. PubMed ID: 9087983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.